These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 3550149

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Prostaglandin E1 versus phentolamine/papaverine for the treatment of erectile impotence: a double-blind comparison.
    Lee LM, Stevenson RW, Szasz G.
    J Urol; 1989 Mar; 141(3):549-50. PubMed ID: 2918589
    [Abstract] [Full Text] [Related]

  • 3. Treatment of impotence by intrapenile injections. A comparison of papaverine versus papaverine and phentolamine: a double-blind, crossover trial.
    Keogh EJ, Watters GR, Earle CM, Carati CJ, Wisniewski ZS, Tulloch GS, Lord DJ.
    J Urol; 1989 Sep; 142(3):726-8. PubMed ID: 2671414
    [Abstract] [Full Text] [Related]

  • 4. Intracavernous injection of vasoactive drugs, an alternative for treating impotence in spinal cord injury patients.
    Wyndaele JJ, de Meyer JM, de Sy WA, Claessens H.
    Paraplegia; 1986 Oct; 24(5):271-5. PubMed ID: 3774363
    [Abstract] [Full Text] [Related]

  • 5. Intracavernous drug-induced erections in the management of male erectile dysfunction: experience with 100 patients.
    Sidi AA, Cameron JS, Duffy LM, Lange PH.
    J Urol; 1986 Apr; 135(4):704-6. PubMed ID: 2421014
    [Abstract] [Full Text] [Related]

  • 6. Intracavernous chlorpromazine versus phentolamine: a double-blind clinical comparative study.
    Shamloul R, El-Dakhly M, Ghanem H, Gadallah A, Mokhtar H.
    J Sex Med; 2004 Nov; 1(3):310-3. PubMed ID: 16422961
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Intracavernous injection of vasoactive drugs for treating erectile impotence].
    Yasumoto R, Asakawa M, Kawashima H, Yoshimura R, Maekawa T, Kashiwara N, Tanaka H, Nishio S.
    Hinyokika Kiyo; 1988 Feb; 34(2):301-4. PubMed ID: 2454019
    [Abstract] [Full Text] [Related]

  • 10. Medical treatment of impotence with papaverine and phentolamine intracavernosal injection.
    Dinsmore WW.
    Ulster Med J; 1990 Oct; 59(2):174-6. PubMed ID: 2278115
    [Abstract] [Full Text] [Related]

  • 11. Intracavernous drug delivery system: an alternative to intracavernous injection in the treatment of impotence?
    Stief CG, Wetterauer U, Kulvelis F, Popken G, Staubesand J, Sommerkamp H.
    Urol Int; 1990 Oct; 45(6):321-5. PubMed ID: 2288047
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Prospective study of the effectiveness and side effects of intracavernous prostaglandin E1 versus papaverine or papaverine phentolamine in the diagnosis and treatment of erection dysfunction. Review of the literature].
    Chandeck Montesa K, Chen Jiménez J, Tamayo JC, Rodríguez Antolín A, Alvarez González E.
    Actas Urol Esp; 1992 Mar; 16(3):208-16. PubMed ID: 1621545
    [Abstract] [Full Text] [Related]

  • 14. Fibrosis of corpus cavernosum after intracavernous injection of phentolamine/papaverine.
    Larsen EH, Gasser TC, Bruskewitz RC.
    J Urol; 1987 Feb; 137(2):292-3. PubMed ID: 3806824
    [Abstract] [Full Text] [Related]

  • 15. Auto-injection of the corpus cavernosum with a vasoactive drug combination for vasculogenic impotence.
    Zorgniotti AW, Lefleur RS.
    J Urol; 1985 Jan; 133(1):39-41. PubMed ID: 2578067
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Intracavernous pharmacotherapy for treatment and evaluation of impotence].
    Vardi Y, Lidgi S, Moskovitz B, Levin RD.
    Harefuah; 1991 Oct; 121(7-8):223-5. PubMed ID: 1783307
    [Abstract] [Full Text] [Related]

  • 18. Pharmacologic erection program for the treatment of male impotence.
    Trapp JD.
    South Med J; 1987 Apr; 80(4):426-7. PubMed ID: 2436316
    [Abstract] [Full Text] [Related]

  • 19. Side effects of self-administration of intracavernous papaverine and phentolamine for the treatment of impotence.
    Levine SB, Althof SE, Turner LA, Risen CB, Bodner DR, Kursh ED, Resnick MI.
    J Urol; 1989 Jan; 141(1):54-7. PubMed ID: 2908954
    [Abstract] [Full Text] [Related]

  • 20. Intracavernous pharmacotherapy for impotence: selection of appropriate agent and dose.
    von Heyden B, Donatucci CF, Kaula N, Lue TF.
    J Urol; 1993 May; 149(5 Pt 2):1288-90. PubMed ID: 8479018
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.